000 | 01239 a2200325 4500 | ||
---|---|---|---|
005 | 20250517110455.0 | ||
264 | 0 | _c20180813 | |
008 | 201808s 0 0 eng d | ||
022 | _a1433-2981 | ||
024 | 7 |
_a10.1016/j.clon.2016.07.004 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aJames, N D | |
245 | 0 | 0 |
_aResponse to 'High Risk of Neutropenia for Hormone-naive Prostate Cancer Patients Receiving STAMPEDE-style Upfront Docetaxel Chemotherapy in Usual Clinical Practice', by Tanguay et al. _h[electronic resource] |
260 |
_bClinical oncology (Royal College of Radiologists (Great Britain)) _c10 2016 |
||
300 |
_a666-7 p. _bdigital |
||
500 | _aPublication Type: Letter; Comment | ||
650 | 0 | 4 | _aAntineoplastic Combined Chemotherapy Protocols |
650 | 0 | 4 | _aDocetaxel |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aNeutropenia |
650 | 0 | 4 | _aProstatic Neoplasms |
650 | 0 | 4 | _aTaxoids |
700 | 1 | _aSydes, M R | |
700 | 1 | _aClarke, N W | |
700 | 1 | _aRitchie, A W S | |
700 | 1 | _aParmar, M K B | |
773 | 0 |
_tClinical oncology (Royal College of Radiologists (Great Britain)) _gvol. 28 _gno. 10 _gp. 666-7 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.clon.2016.07.004 _zAvailable from publisher's website |
999 |
_c26283632 _d26283632 |